Palo Alto Optometrist

03/08/2021

03/08/2021

02/23/2021

12/21/2020

01/20/2020

https://eyewire.news/articles/genentech-roche-initiate-first-diabetic-macular-edema-phase-3-trial-of-the-port-delivery-system-with-ranibizumab/?utm_campaign=Enewsletters&utm_source=hs_email&utm_medium=email&utm_content=82099648&_hsenc=p2ANqtz--_oiPtEg7EQZ-LY7w

06/21/2019

New Acuvue Transition Contact Lenses: Reduces glare outdoors and even with computers. Ask about the lenses at your next appointment.

04/03/2019

https://www.healio.com/optometry/optics/news/online/%7B0f365a82-35d6-4c83-9b6e-1f992730da2c%7D/orasis-ceo-describes-mechanism-behind-eye-drop-for-presbyopia?utm_source=selligent&utm_medium=email&utm_campaign=optometry%20news&m_bt=1026907152155

Orasis Pharmaceuticals recently announced the beginning of a phase 2b U.S. clinical trial to evaluate CSF-1, its presbyopia-correcting eye drop. Primary Care Optometry News spoke with Orasis CEO Elad Kedar about how the drop works and the potential impact on patient care.

01/20/2019

http://drawcuriosity.com/2016/09/4-visual-disturbances-phenomena-experience/

Today I take over Tom Scott's channel to talk about four visual disturbances we all experience on a daily basis.